MolNFT v1 · #119840 · protein
Ctla-4 in complex with tremelimumab Fab
5GGV · Light chain: “Ctla-4 in complex with tremelimumab Fab”. X-ray diffraction, 6 pockets (best druggability 0.59). MolNFT v1 #119840 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5GGV
- Type
- protein
- Length
- 557 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Light chain; Heavy chain; Cytotoxic T-lymphocyte protein 4
- UniProt
- P16410
- Pockets
- 6 · best druggability 0.59
Structure
x-ray diffraction · 3 distinct chains · 7% helix, 51% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| L | Light chain | protein | 213 | 6% helix, 50% strand | — |
| H | Heavy chain | protein | 225 | 9% helix, 50% strand | — |
| Y | Cytotoxic T-lymphocyte protein 4 | protein | 119 | 3% helix, 53% strand | P16410 |
Pockets
6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 153 | 0.59 | 0.83 | 27 | empty |
| 2 | 354 | 0.55 | 0.74 | 52 | empty |
| 3 | 59 | 0.50 | 0.86 | 22 | empty |
| 4 | 87 | 0.31 | 0.72 | 23 | empty |
| 5 | 61 | 0.30 | 0.74 | 17 | empty |
Interfaces
3 interfaces between chains.
- L–H · 1930 Ų buried · 17 hydrogen bonds · protein-protein
- H–Y · 616 Ų buried · 8 hydrogen bonds · protein-protein
- L–Y · 414 Ų buried · 8 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 6 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P16410
- Elsewhere: RCSB PDB 5GGV · PDBe 5GGV · UniProt P16410
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.